×
About 23,594 results

ALLMedicine™ Alzheimer Disease Center

Research & Reviews  11,209 results

APOE Allele Testing and Alzheimer Disease-Reply.
https://doi.org/10.1001/jama.2021.4925
JAMA Choudhury P, Ramanan VK et. al.

Jun 1st, 2021 - APOE Allele Testing and Alzheimer Disease-Reply.|2021|Choudhury P,Ramanan VK,Boeve BF,|

APOE Allele Testing and Alzheimer Disease.
https://doi.org/10.1001/jama.2021.4919
JAMA Chen MH, Yang FC et. al.

Jun 1st, 2021 - APOE Allele Testing and Alzheimer Disease.|2021|Chen MH,Yang FC,Liang CS,|

Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adu...
https://doi.org/10.1371/journal.pmed.1003597
PLoS Medicine; Jin X, He W et. al.

Jun 1st, 2021 - Apolipoprotein E (APOE) ε4 is the single most important genetic risk factor for cognitive impairment and Alzheimer disease (AD), while lifestyle factors such as smoking, drinking, diet, and physical activity also have impact on cognition. The goal...

Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharm...
https://doi.org/10.1371/journal.pmed.1003615
PLoS Medicine; Varma VR, Wang Y et. al.

May 27th, 2021 - While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hypercholesterolemia, the mechanisms underlying this association are unclear. We tested whether dysregulation of cholesterol catabolism, through its conversion to prima...

Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY ...
https://doi.org/10.1161/STROKEAHA.120.031611
Stroke Rost NS, Meschia JF et. al.

May 27th, 2021 - Stroke is a leading cause of the adult disability epidemic in the United States, with a major contribution from poststroke cognitive impairment and dementia (PSCID), the rates of which are disproportionally high among the health disparity populati...

see more →

Guidelines  59 results

Sex Differences in Cognitive Decline Among US Adults
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776902
JAMA Network Open; Levine DA, Gross AL et. al.

Feb 24th, 2021 - Sex differences in dementia risk are unclear. It is known that women have a greater prevalence of Alzheimer disease (AD) than men, at least partly because women live longer.1-3 Some, but not all, studies suggest that women have higher incidence of...

ACR Appropriateness Criteria® Dementia.
https://doi.org/10.1016/j.jacr.2020.01.040
Journal of the American College of Radiology : JACR; , Moonis G et. al.

May 6th, 2020 - Degenerative disease of the central nervous system is a growing public health concern. The primary role of neuroimaging in the workup of patients with probable or possible Alzheimer disease has typically been to exclude other significant intracran...

Falls Risk and Alzheimer Disease: A Patient Guide.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252520
Archives of Physical Medicine and Rehabilitation; Kahya M, Sood P et. al.

Mar 2nd, 2020 - Falls Risk and Alzheimer Disease: A Patient Guide.|2020|Kahya M,Sood P,Devos H,Krishnan S,Hirsch MA,|

In Alzheimer Research, Glucose Metabolism Moves to Center Stage
https://jamanetwork.com/journals/jama/fullarticle/2758712
JAMA Kuehn BM

Jan 7th, 2020 - Areas or patterns of reduced glucose metabolism are often seen in brain scans of patients with Alzheimer disease and other dementias. Now, a growing body of evidence suggests that glucose hypometabolism may be more than just a biomarker on brain s...

Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study
http://www.cmaj.ca/content/191/37/E1018
CMAJ

Sep 15th, 2019 - BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries warn about a possible risk of rhabdomyolysis w...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  11,711 results

APOE Allele Testing and Alzheimer Disease-Reply.
https://doi.org/10.1001/jama.2021.4925
JAMA Choudhury P, Ramanan VK et. al.

Jun 1st, 2021 - APOE Allele Testing and Alzheimer Disease-Reply.|2021|Choudhury P,Ramanan VK,Boeve BF,|

APOE Allele Testing and Alzheimer Disease.
https://doi.org/10.1001/jama.2021.4919
JAMA Chen MH, Yang FC et. al.

Jun 1st, 2021 - APOE Allele Testing and Alzheimer Disease.|2021|Chen MH,Yang FC,Liang CS,|

Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adu...
https://doi.org/10.1371/journal.pmed.1003597
PLoS Medicine; Jin X, He W et. al.

Jun 1st, 2021 - Apolipoprotein E (APOE) ε4 is the single most important genetic risk factor for cognitive impairment and Alzheimer disease (AD), while lifestyle factors such as smoking, drinking, diet, and physical activity also have impact on cognition. The goal...

Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharm...
https://doi.org/10.1371/journal.pmed.1003615
PLoS Medicine; Varma VR, Wang Y et. al.

May 27th, 2021 - While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hypercholesterolemia, the mechanisms underlying this association are unclear. We tested whether dysregulation of cholesterol catabolism, through its conversion to prima...

Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY ...
https://doi.org/10.1161/STROKEAHA.120.031611
Stroke Rost NS, Meschia JF et. al.

May 27th, 2021 - Stroke is a leading cause of the adult disability epidemic in the United States, with a major contribution from poststroke cognitive impairment and dementia (PSCID), the rates of which are disproportionally high among the health disparity populati...

see more →

News  609 results

Sex Differences in Cognitive Decline Among US Adults
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776902
JAMA Network Open; Levine DA, Gross AL et. al.

Feb 24th, 2021 - Sex differences in dementia risk are unclear. It is known that women have a greater prevalence of Alzheimer disease (AD) than men, at least partly because women live longer.1-3 Some, but not all, studies suggest that women have higher incidence of...

Fast Five Quiz: Alzheimer Disease Management
https://reference.staging.medscape.com/viewarticle/912045_2

Aug 18th, 2020 - Answer 1/5 Which of the following is the current standard pharmacologic treatment for Alzheimer disease in the United States and Europe? Your peers chose: Carbidopa/levodopa/entacapone 0% Cholinesterase inhibitors (ChEIs) and partial N-methyl-D-as...

Fast Five Quiz: Alzheimer Disease Management
https://reference.staging.medscape.com/viewarticle/912045

Aug 18th, 2020 - Alzheimer disease is a chronic, neurodegenerative disorder of the aging population that results in progressive cognitive and behavioral dysfunction. Afflicting more than 6 million Americans and more than 8 million Europeans, Alzheimer disease is t...

Fast Five Quiz: Alzheimer Disease Management
https://reference.staging.medscape.com/viewarticle/912045_5

Aug 18th, 2020 - In addition to the medications approved for Alzheimer disease, regular physical and cognitive exercise routines are strategies to prevent and slow disease progression. Increased cardiorespiratory fitness levels are associated with higher hippocamp...

Fast Five Quiz: Alzheimer Disease Management
https://reference.medscape.com/viewarticle/912045_3

Aug 18th, 2020 - Answer 2/5 Which of the following has been shown to achieve the highest levels of cognitive and functional abilities in patients with Alzheimer disease? Your peers chose: Early diagnosis and treatment 0% Antidepressants 0% Loop diuretics and CCBs ...

see more →

Patient Education  1 results see all →